Review
Published on 23 May 2023
Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1185163
- 2,443 views
- 4 citations
Type at least 3 characters
1,297 articles
Articles
Original Research
Published on 23 May 2023
Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1171926
- 2,054 views
Case Report
Published on 22 May 2023
Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1149450
- 4,521 views
- 4 citations
Review
Published on 19 May 2023
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1135430
- 3,250 views
- 3 citations
Original Research
Published on 18 May 2023
Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1192192
- 1,424 views
- 3 citations
Original Research
Published on 18 May 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1145667
- 1,482 views
- 1 citation
Original Research
Published on 16 May 2023
Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1180722
- 1,447 views
Original Research
Published on 16 May 2023
The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1096955
- 1,588 views
- 2 citations
Original Research
Published on 12 May 2023
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1134824
- 1,211 views
Original Research
Published on 12 May 2023
Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1162360
- 2,018 views
- 5 citations
Case Report
Published on 10 May 2023
Multi-protocol exploratory treatment for metastatic castration-resistant prostate cancer with BRCA mutations: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1177941
- 1,666 views
- 1 citation
Original Research
Published on 10 May 2023
Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1195520
- 2,631 views
- 3 citations
Original Research
Published on 10 May 2023
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1116937
- 2,222 views
- 4 citations
Review
Published on 10 May 2023
Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1114042
- 2,386 views
- 6 citations
Original Research
Published on 09 May 2023
Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1163695
- 1,567 views
- 1 citation
Original Research
Published on 09 May 2023
Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1177120
- 1,811 views
- 1 citation